News & Updates

Among patients with chronic coronary syndromes, those with higher serum uric acid (SUA) levels are more likely to have major adverse cardiovascular (CV) events (MACE) and worse related quality of life (QoL), as reported in a study.

The development of nonalcoholic fatty liver disease (NAFLD) and progression of fibrosis contribute to a higher risk of incident chronic kidney disease (CKD), suggests a recent study.

Both exogenous hyper- and hypothyroidism may increase the risk of incident stroke, according to a study, which notes the importance of patient medication safety.

Hypertension and diabetes are the major predictors of stroke that must be controlled and treated like other global high-risk populations for stroke prevention, according to a prospective study in India.

Individuals with fatty pancreas appear to be at heightened risk of developing subsequent diabetes mellitus, but not hypertension or dyslipidaemia, as suggested in a study.

The osteoporosis drug alendronate halves the risk of developing type 2 diabetes (T2D) in a nationwide, retrospective, case-control study of nearly 700,000 patients from Denmark.

Patients with heart failure and preserved ejection fraction (HFpEF) treated with dapagliflozin experienced improvements in symptoms and physical limitations, according to results of the PRESERVED-HF study presented at HFSA 2021.